Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
ASBMR 2023: American Society for Bone and Mineral Research
Scintica welcomes you to join us at ASBMR 2023, the American Society for Bone and Mineral Research. We invite you to join us in creating a vibrant atmosphere where collaborations flourish, new discoveries are made, and the future of bone and mineral research is shaped. We are thrilled to be exhibiting this year and are looking forward to having the opportunity to discuss how we can help support your preclinical research! Together, let’s illuminate the path toward a healthier future for bone and mineral health!
When does the Meeting Take Place?
Friday, October 13 – Monday, October 16
Where is this year’s ASBMR 2023 Annual Meeting?
Vancouver Convention Centre, Vancouver, BC
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders